Metabolic Basis of Primary Hypercholesterolemia
Gloria Lena Vega, PhD; Margo A. Denke, MD; and Scott M. Grundy, MD, PhD Background. Hypercholesterolemia is a well-established risk factor for coronary heart disease. However, the mechanisms underlying hypercholesterolemia, elevated low density lipoprotein (LDL) in particular, are not well understood. To determine these mechanisms, we studied LDL kinetics in a group of men with primary hypercholesterolemia. Methods and Results. LDL kinetics in 134 middle-aged men with high-risk levels of LDL cholesterol (more than 160 mg/dl) were compared with kinetics in 16 men with borderline high-risk levels of LDL cholesterol (120-159 mg/dl) and 14 men with heterozygous familial hypercholesterolemia (FH). Patients with primary hypercholesterolemia (non-FH) were further divided into moderate hypercholesterolemia (LDL cholesterol, 160-210 mg/dl; n=108) and severe hypercholesterolemia groups (LDL cholesterol, more than 210 mg/dl; n=26). Four factors contributed to increasing LDL cholesterol concentrations above the borderline range to moderately elevated levels: 37 patients had no increase in LDL apolipoprotein (apo) B levels but had abnormally high LDL cholesterol-to-apo B ratios; 14 patients had very low fractional catabolic rates (FCRs) for LDL, similar to FH patients; 35 patients had FCRs for LDL in the borderline range but high production rates for LDL; and 22 patients had a high flux of LDL (high production rates and high FCRs). In general, patients with severe hypercholesterolemia resembled those with moderate LDL elevations, except that their LDL particles were enriched with cholesterol.
Conclusions. Data from the present study reveal that there are several distinct patterns of LDL metabolism responsible for primary hypercholesterolemia. These patterns can serve as the basis for further investigation to determine the molecular defects responsible for each pattern. (Circulation 1991; 84:118-128) H ypercholesterolemia is a well-established risk factor for coronary heart disease. Recently, the National Cholesterol Education Program (NCEP) identified low density lipoprotein (LDL) cholesterol as the primary target of therapy in patients with hypercholesterolemia.' A high-risk LDL cholesterol level was defined as a serum level of more than 160 mg/dl, which is present in approximately 25% of adult US men. A borderline high-risk LDL cholesterol level encompasses the range of 130-159 mg/dl and is present in approximately 40% of adult US men. The mechanisms responsible for high-risk LDL cholesterol levels are not well understood, although primary hypercholesterolemia is in general believed to be the result of reduced activity of LDL receptors.2
In the present study, LDL metabolism causing highrisk LDL cholesterol levels was examined using tracer kinetics. Patients with primary forms of moderate and severe hypercholesterolemia were compared with subjects with borderline high-risk levels of LDL cholesterol. The purpose of the study was to identify factors that increase LDL cholesterol concentrations to the high-risk range rather than to the borderline high-risk zone. Among those with high-risk levels, patients with moderate and severe hypercholesterolemia were compared so that factors determining the severity of hypercholesterolemia could be defined.
Methods Patients
Patients in the present study comprised three groups. The largest group included 134 men with primary hypercholesterolemia in whom clinical evi-dence of heterozygous familial hypercholesterolemia (FH) was lacking (see below). The Mean age of patients in this group was 55.5±12 (±SD) years (range, years). Sixty-seven patients had a history of coronary artery disease as manifest by history of angina pectoris, myocardial infarction, or coronary artery surgery, the latter two occurring at least 6 months before entry into the study. Twenty-eight patients had a history of hypertension. Patients with coronary artery disease or hypertension were receiving a variety of drugs for these conditions, the doses of which were not altered during the study. Data from 38 of the 134 patients have been previously presented elsewhere. [6] [7] [8] Borderline high LDL cholesterol group. The patients in this group had estimated LDL cholesterol concentrations ranging from the 25th to the 75th percentile for men 40-54 years old of the Lipid Research Clinics Prevalence Study.9 These percentiles essentially correspond to estimated LDL cholesterol levels of 120-159 mg/dl. Because these values are similar to those defined as borderline high-risk LDL cholesterol by the NCEP' (i.e., levels of 130-159 mg/dl), patients in this group were designated as having borderline high LDL cholesterol, and the entire group was called the "borderline group." Mean estimated LDL cholesterol for this group was 137±16 mg/dl; this mean value approximates the 50th percentile for those in the age range of the group, and although it may be slightly lower than the average borderline high-risk LDL cholesterol level for the general middle-age population,' the designation "borderline" appears to be reasonable. None of the patients in this group had a history of angina pectoris or myocardial infarction. Their average age was 55 ± 12 years. Subjects were generally healthy and not receiving medication. Data from 12 of these men have been previously published elsewhere. 10 Heterozygous FH. This group contained 14 male patients (mean age, 43 ± 11 years) who were considered to have heterozygous FH. This diagnosis was made on the basis of a history of severe hypercholesterolemia and, in most patients, tendon xanthomas, very premature coronary heart disease, and a strong family history of hypercholesterolemia, tendon xanthomas, and/or premature coronary heart disease. 5 The patients were not tested for abnormal binding of LDL to cultured skin fibroblasts. The data for these patients have been previously presented elsewhere." Experimental Design Three weeks before starting the LDL turnover study, the patients were instructed to consume a diet consisting of 40% of total calories as fat (18% saturates, 17% monounsaturates, and 5% polyunsaturates), 45% as carbohydrates, and 15% as protein.
Daily intake of cholesterol averaged 300-400 mg/ day. The diet was composed mainly of solid foods and has been previously described. [6] [7] [8] During the third week on this diet, patients underwent a l-unit plasmapheresis. The Fraction of injected radioactivity remaining in plasma was plotted as a function of time, and the resulting curve in disappearance of labeled LDL from plasma was used to calculate FCRs for LDL. The curves were consistently biexponential, and they were assumed to conform to a two-pool model16; according to this model, input and exit of LDL occurred from an intravascular pool that was in equilibrium with an extravascular pool. The FCR was estimated by simulation analysis. The size of the intravascular pool of LDL apo B was determined by multiplying the concentration of LDL apo B by the plasma volume. The method for estimating LDL apo B concentration is described below. The plasma pool size for LDL apo B was estimated by isotope dilution from the sample taken at 10 minutes. The input rate (transport rate) for LDL apo B was estimated as the product of pool size and FCR for LDL apo B. The input of LDL is generally believed to be derived from catabolism of triglyceride-rich lipoproteins. Irreversible exits of LDL from plasma can occur via LDL receptor or nonreceptor pathways, the former usually predominating.2 Experience has shown that the FCR for LDL apo B is a reflection of availability of LDL receptors, although this relation does not pertain under all circumstances.
Plasma Lipid and Lipoproteins
Plasma concentrations of total cholesterol, triglycerides, and lipoprotein cholesterol were measured enzymatically as described previously.15 Total cholesterol17 and triglycerides'8 were determined on whole plasma.
HDL cholesterol was measured after precipitation of apo B-containing lipoproteins in whole plasma with heparin manganese.19 Another aliquot of plasma was used to isolate very low density lipoprotein (VLDL) and IDL (density, less than 1.019 g/dl) by ultracentrifugation. Cholesterol was determined in the isolated 1.019 g/ml supranatant and plasma infranatant. Corrections were made for total recoveries that were consistently more than 96%. LDL cholesterol was calculated as the difference between 1.019 g/ml infranatant cholesterol and HDL cholesterol.
Determination of LDL Apolipoprotein B Concentration
The true LDL fraction (density, 1.019-1.063 g/ml) was isolated by preparative ultracentrifugation from the five samples selected for lipoprotein analysis. The cholesterol content was determined enzymatically and protein (apo B) was measured by the Lowry method (Lowry et a120), as modified by Markwell et a12' and described in detail previously. 22 The absolute plasma level of LDL apo B was estimated by multiplying the absolute concentration of LDL cholesterol (as determined above) by the LDL apo B-to-cholesterol ratio (determined on the isolated LDL fraction). The LDL apo B concentration taken for each patient represented the mean of the five measurements. Phenotyping ofApolipoprotein E Phenotyping of apo E was performed on 84 patients according to borderline patients, whereas others had elevated input rates. In Figure 2, 14 had reduced FCRs for LDL apo B (less than 0.25 pools per day); these low FCRs were mainly responsible for the patients' high levels of LDL cholesterol. The average input rate for LDL apo B in this subgroup did not differ significantly from that of borderline patients. LDL cholesterol-to-apo B ratios were neither increased nor decreased for this group; none of the patients had ratios of less than 1.25, which is often seen in patients with hypertriglyceridemia38,39 or hyperapobetalipoproteinemia.40-42 Two of the 14 patients in this group were found to have familial defective apo B-100 (3500 mutation). [26] [27] [28] Thirty-five other patients with moderate hypercholesterolemia had midrange FCRs for LDL (0.25-0.40 pools per day). The body mass indexes in this subgroup were significantly higher than those of borderline subjects (Table 2) . Compared with the latter, input rates also were significantly elevated, which in large part explains their higher LDL cholesterol level. Their FCRs and LDL apo B-to-cholesterol ratios were on (Table 3) . Their average LDL cholesterol-toapo B ratios were neither increased nor decreased compared with those of the borderline group; however, two patients in this subgroup had a ratio of less than 1.25. levels, they primarily differed from patients with moderate hypercholesterolemia by having significantly higher LDL cholesterol-to-apo B ratios. The same was essentially true for the smaller subgroups with midrange and high FCRs. None of the patients had low ratios (1.25 or less). Thus, a higher LDL cholesterol-to-apo B ratio was the major factor responsible for higher LDL cholesterol levels in patients with severe hypercholesterolemia compared with those with moderate hypercholesterolemia, regardless of FCRs for LDL apo B. Two patients in the subgroup with low FCRs were found to have familial defective apo B-100 (3500 mutation). [26] [27] [28] Apo E phenotypes were determined in 84 patients with both types of hypercholesterolemia. Their frequencies are compared with those reported by Havel43 for the general population (values in parentheses). Percentages of phenotypes were distributed as follows: E-4:E-4, 1% (3%); E-3:E-3, 45% (55%); E-2:E-2, 0% (1%); E-4:E-3, 33% (26%); E-4:E-2, 1% (3%); and E-3: E-2, 20% (12%). Hypercholesterolemic patients of this study appeared to not have an overall enrichment of phenotypes containing E-4. Examination of subgroups did not reveal a selective increase of either E-4 or other E isoforms. Of the 100 patients who were tested for familial defective apo B-100, four unrelated patients were found to have this abnormality.
Discussion
The primary purpose of the present study was to determine the general mechanisms responsible for high-risk LDL cholesterol (termed "primary hypercholesterolemia' in this article and defined as an estimated LDL cholesterol level of more than 160 mg/dl). In the present study, hypercholesterolemia was present while patients consumed a "typical" American diet (i.e., a diet relatively high in saturated fatty acids and cholesterol). This diet resembled that consumed by free-living Americans, and levels of LDL cholesterol and parameters of LDL apo B metabolism thus obtained should be representative of hypercholesterolemic, middle-aged US men. We compared hypercholesterolemic patients with subjects who had borderline high-risk LDL cholesterol levels. Our main purpose was to explain increases of LDL cholesterol above the borderline range, not those above the desirable range or a hypothetical "normal" level. Primary hypercholesterolemia was further divided into moderate and severe forms, and metabolic parameters obtained for these two forms were compared with one another and with patients with heterozygous FH. Next, we separately consider mechanisms for borderline high LDL cholesterol, moderate hypercholesterolemia, and severe hypercholesterolemia.
Borderline High LDL Cholesterol
The NCEP1 defined borderline high-risk LDL cholesterol as a serum level in the range of 130-159 mg/dl. In the present study, one group of subjects had LDL levels essentially in this range and thus served as the reference group. According to epidemiologic studies,44-47 cholesterol levels in the borderline zone increase risk for coronary heart disease above that in the desirable range. Furthermore, in the United States, more adult men have borderline high LDL than any other defined range of LDL cholesterol.1 9 Therefore, mechanisms responsible for borderline increases of LDL cholesterol are of great interest and public health significance. At least three factors have been identified as increasing LDL cholesterol levels to the borderline zone in middle-aged Americans: relatively high intakes of cholesterol and saturated fatty acids,48 the unexplained increase in serum cholesterol with age,9 and obesity.49-51 High intakes of cholesterol52 and saturated fatty acids53-55 appear to depress LDL receptor activity; enrichment of liver cells with dietary cholesterol directly suppresses synthesis of LDL receptors,52 but mechanisms whereby saturated fatty acids reduce activity of LDL receptors are not known. The increase of LDL cholesterol with aging also appears to result in large part from a decrease in LDL receptor activity,10,56 although the precise mechanism is not understood. Finally, the high prevalence of obesity among middleaged Americans probably contributes to higher LDL levels.48-50 A high intake of cholesterol and saturated fatty acids in many obese people will suppress LDL receptor activity, but obesity can also stimulate overproduction of apo B-containing lipoproteins,57,58 which should increase LDL concentrations. Therefore, a diminished LDL receptor activity appears to be the major factor, although perhaps not the only factor, responsible for borderline high LDL levels; in the present study, we attempted to determine the extent to which this also is true of patients with LDL cholesterol levels in the high-risk range.
Primary Moderate Hypercholesterolemia
Patients in the present study with borderline high concentrations of LDL cholesterol had FCRs for LDL averaging 0.31 pools per day. As indicated previously, this average value was relatively low because of a low activity of LDL receptors secondary to diet and age. One mechanism for development of high-risk LDL cholesterol concentrations could be still further suppression of LDL receptor activity. If this is the major factor responsible for the incremental increase of LDL cholesterol levels above the borderline zone, still lower FCRs for LDL might be expected. Because of the widely held belief that hypercholesterolemia is in large part a result of reduced activity of LDL receptors,2 it might be expected that the majority of patients with moderate hypercholesterolemia would have a further reduction in FCRs for LDL. This was not observed, however, and the characteristics of different patterns of LDL kinetics for this group will therefore be considered.
Low FCRs for LDL. Among patients with moderate hypercholesterolemia and an LDL apo B level of more than 110 mg/dl, 13% had low FCRs for LDL, defined as FCRs of less than 0.25 pools per day (Table 1) . A few hypercholesterolemic patients with LDL apo B concentrations less than 110 mg/dl also had low FCRs for LDL (Figure 2 ). Other patients had FCRs between 0.25 and 0.30 pools per day, but as shown in Figure 2 Of interest, more than half of the patients in this group had low FCRs for LDL apo B (FCRs, less than 0.25 pools per day). Thus, low FCRs, whether resulting from low activity of LDL receptors or defective apo B-100, appeared to be an important factor responsible for primary severe hypercholesterolemia. On the other hand, the kinetic parameters for LDL apo B in this group were not significantly different from those of corresponding low-FCR patients with moderate hypercholesterolemia. The factor that transformed them into the severe category was a significantly higher LDL cholesterol-to-apo B ratio. In other words, not only did these patients have low
FCRs, but their LDL particles were overloaded with cholesterol. The same phenomenon was responsible for severe hypercholesterolemia in the relatively few patients with midrange FCRs and high FCRs. Again, these latter subgroups did not differ in LDL apo B kinetics from the corresponding category with moderate hypercholesterolemia, but instead their LDL particles were overloaded with cholesterol.
These findings in severely hypercholesterolemic patients further emphasize the need to examine the causes of accumulation of excess cholesterol in LDL particles. One cause might be a relatively low FCR for LDL, because the FH heterozygotes also had cholesterol-enriched LDL (Table 1) . However, the fact that a subgroup of moderately hypercholesterolemic patients with midrange FCRs and all categories with severe hypercholesterolemia had high LDL cholesterol-to-apo B ratios speaks against the concept that a low FCR is the only factor responsible for overloading LDL particles with cholesterol. The possibility that these patients had abnormalities in activity of cholesterol ester transfer protein or lecithin cholesterol acyltransferase is intriguing and worth further exploration.
Conclusions
Results from the present study show that primary hypercholesterolemia can result from several different causes. A suppression of LDL receptor activity, secondary to high intakes of saturated fatty acids and cholesterol and the unexplained increase of LDL with age, appears to drive the LDL level into the borderline high zone in many people. Additional factors are apparently required to increase levels to the high-risk zone in approximately 25% of middle-aged US men. In some individuals, further suppression of LDL receptor activity appears responsible. In others, high inputs of LDL apo B were responsible; in some of these people, high input rates may be related to obesity, but in others, defects in metabolism of precursor lipoproteins (VLDL and IDL) are probably responsible. Finally, one of the more interesting findings of the present study was that enrichment of LDL particles with cholesterol is a significant factor contributing to hypercholesterolemia, particularly in patients with severe elevations of LDL cholesterol.
